'Immediate and long-term health benefits' from reduction in sulphur emissions

November 21, 2002

Reducing the sulphur content of pollutants can have a substantial impact in reducing death from respiratory and cardiovascular diseases, conclude authors of a study in this week's issue of THE LANCET which describes the effect of a public-health initiative in Hong Kong.

A change in law to restrict sulphur emissions was introduced in Hong Kong in July 1990; all power plants and road vehicles had to use fuel oil with a sulphur content restricted to not more than 0·5% by weight. This intervention led to an immediate fall in ambient sulphur dioxide concentration.

Anthony Johnson Hedley and colleagues from the University of Hong Kong and St. George's Hospital Medical School, London, assessed the effect of this intervention on death from various causes in Hong Kong in the first five years after the sulphur-emissions restriction was introduced, providing comparisons with mortality data for the five years before the law change.

The decrease in ambient sulphur dioxide concentrations after the intervention led to a decline in the average annual trend in deaths from all causes of around 2%. The greatest impact of the policy change was a reduction in deaths from respiratory disease of nearly 5% and a 2% reduction in deaths from cardiovascular disease. In terms of increased survival, the intervention was estimated to result in a 20-day lifetime increase for women and 40 days increased life expectancy on average for men.

Anthony Hedley comments: "Pollution resulting from sulphur-rich fuels has an effect on death rates, especially respiratory and cardiovascular deaths. The outcome of the Hong Kong intervention provides direct evidence that control of this source of pollution has immediate and long-term health benefits."
-end-
Contact: Professor A J Hedley, Department of Community Medicine & Unit for Behavioural Sciences,
University of Hong Kong, 5/F, Academic and Administration Block, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong;
T) 852-2819-9282;
F) 852-2855-9528;
E) commed@hkucc.hku.hk

Lancet

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.